Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Lidocaine
Drug ID BADD_D01287
Description Ever since its discovery and availability for sale and use in the late 1940s, lidocaine has become an exceptionally commonly used medication [T583]. In particular, lidocaine's principal mode of action in acting as a local anesthetic that numbs the sensations of tissues means the agent is indicated for facilitating local anesthesia for a large variety of surgical procedures [F4349, L5930, L5948]. It ultimately elicits its numbing activity by blocking sodium channels so that the neurons of local tissues that have the medication applied on are transiently incapable of signaling the brain regarding sensations [F4349, L5930, L5948]. In doing so, however, it can block or decrease muscle contractile, resulting in effects like vasodilation, hypotension, and irregular heart rate, among others [F4349, L5930, L5948]. As a result, lidocaine is also considered a class Ib anti-arrhythmic agent [L5930, L5948, F4468]. Nevertheless, lidocaine's local anesthetic action sees its use in many medical situations or circumstances that may benefit from its action, including the treatment of premature ejaculation [A177625]. Regardless, lidocaine is currently available as a relatively non-expensive generic medication that is written for in millions of prescriptions internationally on a yearly basis. It is even included in the World Health Organization's List of Essential Medicines [L6055].
Indications and Usage For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.
Marketing Status Prescription; Discontinued
ATC Code C01BB01; C05AD01; D04AB01; N01BB02; R02AD02; S01HA07; S02DA01
DrugBank ID DB00281
KEGG ID D00358
MeSH ID D008012
PubChem ID 3676
TTD Drug ID D0X4RN
NDC Product Code 60760-408; 46581-830; 71589-001; 45865-922; 16714-878; 82212-001; 69006-010; 41167-0598; 41250-625; 69842-543; 41163-606; 0363-3001; 0536-1339; 71309-911; 71811-001; 73622-3077; 66064-1011; 0591-3525; 72288-413; 72559-018; 52932-0702; 49947-002; 71594-600; 68071-2460; 70466-001; 79481-0004; 58133-650; 65162-918; 69263-851; 50488-6262; 69968-0614; 55910-912; 21130-733; 0404-9890; 71205-500; 80919-001; 54723-002; 68788-7159; 68788-7865; 69898-003; 63940-911; 71101-011; 51927-0154; 58980-823; 0113-7700; 0168-0204; 62168-0584; 70897-001; 63824-257; 71205-549; 25119-5000; 68788-6319; 69693-414; 67510-0283; 72559-016; 0603-1880; 63868-309; 80327-004; 61281-2500; 10135-672; 63742-001; 72854-682; 39328-024; 52565-122; 41250-972; 11527-191; 62168-0585; 53943-911; 24689-124; 59088-811; 41167-0585; 0496-0892; 68788-7617; 11673-744; 51407-325; 73240-004; 54723-001; 71205-288; 46122-555; 72189-165; 70896-2027; 72288-949; 71383-014; 63629-8848; 58443-0298; 73486-102; 11523-0404; 49035-717; 78280-712; 71205-429; 67234-052; 50488-6263; 71262-006; 0395-8133; 60203-1003; 49035-860; 65479-1202; 0362-0221; 64032-0006; 76420-037; 63742-006; 66902-225; 45865-950; 27854-311; 0363-9110; 69336-103; 0536-1281; 49452-4040; 67877-473; 70518-2147; 58443-0204; 70281-640; 0113-7219; 41167-0583; 68071-4628; 77375-007; 51672-3020; 41167-0584; 52410-3077; 71101-911; 69263-852; 71205-137; 73115-000; 24909-901; 79481-0005; 60760-880; 63629-2504; 69805-786; 50436-3525; 69664-001; 71073-206; 11527-384; 46122-652; 66902-215; 55154-2665; 55700-142; 45865-911; 49035-136; 64380-789; 69159-003; 33342-405; 60203-1002; 46581-840; 55264-106; 73033-004; 70752-113; 50436-0473; 0536-1139; 69097-590; 45865-837; 55700-932; 63187-975; 72835-502; 50090-1352; 73581-105; 76420-131; 63187-934; 50383-341; 45865-912; 73096-050; 71085-011; 50488-2004; 79481-0003; 72288-361; 69191-500; 50066-224; 49873-617; 68788-7766; 81238-5000; 0496-0882; 73423-009; 71383-024; 30142-697; 0363-9116; 70000-0557; 63629-7059; 71205-342; 69145-201; 59088-714; 78280-703; 60760-473; 82460-262; 66902-450; 63742-002; 22568-1014; 50804-838; 73354-1279; 0363-9226; 75834-141; 63629-5094; 72189-168; 62332-424; 55629-060; 11822-6541; 72288-171; 65923-149; 63742-110; 71052-236; 80327-000; 71226-002; 52584-282; 71085-001; 60760-918; 73377-139; 59088-712; 68071-1723; 69557-111; 72835-501; 76420-125; 71399-4456; 52565-008; 63742-111; 69993-425; 69747-040; 59088-807; 0378-9055; 68071-2322; 62991-1094; 69842-107; 76420-036; 72189-211; 51151-738; 0404-9893; 69842-236; 35781-0300; 76282-669; 35192-027; 73096-052; 73408-260; 79572-020; 0113-7200; 69903-001; 82022-000; 21130-960; 54723-200; 69664-002; 0536-1202; 73096-049; 70518-3056; 72559-012; 52119-001; 73287-024; 27789-911; 17856-3008; 0113-8000; 76348-605; 0536-1278; 70645-735; 12660-0033; 82022-001; 63481-687; 73638-901; 67234-067; 79218-001; 51672-3008; 71594-602; 70000-0366; 81238-4600; 60760-201; 49911-884; 69842-663; 55154-7228; 63275-9912; 61919-774; 55621-011; 72288-750; 52119-008; 80327-006; 51407-383; 49947-001; 73581-911; 63629-2503; 0496-0883; 76348-415; 73033-001; 70512-012; 73581-001; 51552-0145; 80327-008; 72667-008; 73096-064; 71335-1971; 80327-005; 73557-156; 71101-915; 69903-004; 16714-177; 60000-911; 52584-904; 45865-990; 27854-333; 68462-418; 0591-2679; 51532-3806; 69396-070; 70000-0468; 71335-1934; 0536-1267; 41520-789; 35192-026
Synonyms Lidocaine | 2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide | 2-2EtN-2MePhAcN | Lignocaine | Lidocaine Carbonate (2:1) | Lidocaine Carbonate | Lidocaine Hydrocarbonate | Lidocaine Hydrochloride | Lidocaine Monohydrochloride | Lidocaine Monoacetate | Xyloneural | Lidocaine Sulfate (1:1) | Octocaine | Xylesthesin | Xylocaine | Xylocitin | Dalcaine | Lidocaine Monohydrochloride, Monohydrate
Chemical Information
Molecular Formula C14H22N2O
CAS Registry Number 137-58-6
SMILES CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Drug toleranceAlpha-1-acid glycoprotein 1P02763Not Available3563124; 7249498; 6705424
Gastrointestinal disordersEndoplasmic reticulum chaperone BiPP11021T7759412624106; 15944403; 9092938
HepatitisAlkaline phosphatase, placental typeP05187Not Available8182888; 7637162; 12945030; 11925898; 8640096; 10399520; 2304244; 7588020; 11465567
HepatitisAlanine aminotransferase 2Q28DB5Not Available8182888; 7637162; 12945030; 11925898; 8640096; 10399520; 2304244; 7588020; 11465567; 10432943
HepatitisGlutathione hydrolase 1 proenzymeP19440Not Available8182888; 7637162; 12945030; 11925898; 8640096; 10399520; 2304244; 7588020; 11465567
HepatitisAlanine aminotransferase 2Q28DB5Not Available8182888; 7637162; 12945030; 11925898; 8640096; 10399520; 2304244; 7588020; 11465567
PyrexiaAlanine aminotransferase 2Q28DB5Not Available8182888; 7637162; 12945030; 11925898; 8640096; 10399520; 2304244; 7588020; 11465567
PyrexiaAlkaline phosphatase, placental typeP05187Not Available8182888; 7637162; 12945030; 11925898; 8640096; 10399520; 2304244; 7588020; 11465567
PyrexiaAlanine aminotransferase 2Q28DB5Not Available8182888; 7637162; 12945030; 11925898; 8640096; 10399520; 2304244; 7588020; 11465567; 10432943
PyrexiaGlutathione hydrolase 1 proenzymeP19440Not Available8182888; 7637162; 12945030; 11925898; 8640096; 10399520; 2304244; 7588020; 11465567
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Rash23.03.13.0010.001536%Not Available
Respiratory arrest22.02.01.009--Not Available
Respiratory depression22.02.01.010; 17.02.05.047--Not Available
Respiratory paralysis22.02.06.003; 17.01.04.010--Not Available
Rhinitis22.07.03.006; 11.01.13.004--
Sedation17.02.04.005--Not Available
Seizure17.12.03.0010.000100%
Sensory disturbance17.02.07.006--Not Available
Sensory loss17.02.07.007--Not Available
Shock24.06.02.002--Not Available
Skin depigmentation23.05.02.002--Not Available
Skin exfoliation23.03.07.003--Not Available
Skin irritation23.03.04.009--Not Available
Skin lesion23.03.03.010--Not Available
Somnolence19.02.05.003; 17.02.04.006--
Spinal anaesthesia25.01.03.001--Not Available
Stomatitis07.05.06.005--
Tenderness08.01.08.005--Not Available
Tension19.06.02.005--Not Available
Teratogenicity12.03.01.032; 03.02.01.004--Not Available
Tinnitus17.04.07.004; 04.04.01.002--
Tongue discolouration07.14.02.006--Not Available
Tremor17.01.06.002--
Urinary incontinence20.02.02.010; 17.05.01.008--
Urinary retention20.02.02.011--
Urticaria23.04.02.001; 10.01.06.0010.000576%
Ventricular fibrillation02.03.04.008--
Ventricular tachycardia02.03.04.010--
Vision blurred17.17.01.010; 06.02.06.007--
Visual impairment06.02.06.008--Not Available
The 4th Page    First    Pre   4 5    Next   Last    Total 5 Pages